Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians

被引:26
作者
Gambhir, Jasvinder K. [1 ]
Kaur, Harsimrut [1 ]
Prabhu, Krishna M. [1 ]
Morrisett, Joel D. [2 ]
Gambhir, DaIjeet S. [3 ]
机构
[1] Univ Coll Med Sci, Dept Biochem, Delhi 110095, India
[2] Baylor Coll Med, Dept Med & Biochem, Houston, TX 77030 USA
[3] Kailash Heart Inst, Noida, India
关键词
Lp(a) level; apo(a) isoforms; immunoblotting; KIV type-2 repeats; heterozygosity; positive family; history of CAD;
D O I
10.1016/j.clinbiochem.2008.01.016
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The purpose of this study was to explore the association between lipoprotein (a) [Lp(a)] levels, apo(a) isoforms and family history of premature coronary artery disease (CAD) in young Asian Indians. Design and methods: 220 patients (age <40 years) with angiographic evidence of CAD and 160 age matched healthy controls were enrolled for the study. Thirty one percent of the patients and 17% of the controls had positive family history (PFH) of premature CAD. Plasma Lp(a) levels were determined by ELISA and apo(a) isoform size was determined using high-resolution immunoblotting method. Results: Median plasma Lp(a) levels were 2.5 times higher in patients as compared to controls (30 mg/dL vs 12.7 mg/dL; p<0.05). The patient group having a heterozygous apo(a) isoform pattern showed higher Lp(a) levels as compared to the homozygous group (44.0 +/- 38.7 vs 28.0 +/- 26.4 mg/dL;p<0.001). Further low molecular weight apo(a) isoforms (LMW; <22 KIV repeats) were prevalent among CAD patients with PFH as compared to negative family history (62% vs 14%,p<0.05) and this group had the highest Lp(a) levels. Stepwise regression analysis showed that Lp(a) levels and not the apo(a) isoform size, entered the model as significant independent predictors of CAD in young Asian Indians. Conclusions: This study suggests that elevated Lp(a) levels confer genetic predisposition to CAD in young Asian Indians. Thus determination of Lp(a) levels along with other risk factors should be used to assess overall risk for CAD in this ethnic group. (c) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 36 条
[1]   GENETICS OF THE QUANTITATIVE LP(A) LIPOPROTEIN TRAIT .3. CONTRIBUTION OF LP(A) GLYCOPROTEIN PHENOTYPES TO NORMAL LIPID VARIATION [J].
BOERWINKLE, E ;
MENZEL, HJ ;
KRAFT, HG ;
UTERMANN, G .
HUMAN GENETICS, 1989, 82 (01) :73-78
[2]   APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS [J].
BOERWINKLE, E ;
LEFFERT, CC ;
LIN, JP ;
LACKNER, C ;
CHIESA, G ;
HOBBS, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :52-60
[3]   Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study [J].
Brazier, L ;
Tiret, L ;
Luc, G ;
Arveiler, D ;
Ruidavets, JB ;
Evans, A ;
Chapman, J ;
Cambien, F ;
Thillet, J .
ATHEROSCLEROSIS, 1999, 144 (02) :323-333
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].
Danesh, J ;
Collins, R ;
Peto, R .
CIRCULATION, 2000, 102 (10) :1082-1085
[6]   Screening of family members of patients with premature coronary heart disease -: Results from the EUROASPIRE II family survey [J].
De Sutter, J ;
De Bacquer, D ;
Kotseva, K ;
Sans, S ;
Pyörälä, K ;
Wood, D ;
De Backer, G .
EUROPEAN HEART JOURNAL, 2003, 24 (03) :249-257
[7]   LIPOPROTEIN-ALPHA INHIBITS STREPTOKINASE-MEDIATED ACTIVATION OF HUMAN-PLASMINOGEN [J].
EDELBERT, JM ;
GONZALEZGRONOW, M ;
PIZZO, SV .
BIOCHEMISTRY, 1989, 28 (06) :2370-2374
[8]   MALIGNANT CORONARY-ARTERY-DISEASE IN YOUNG ASIAN INDIANS - THOUGHTS ON PATHOGENESIS, PREVENTION, AND THERAPY [J].
ENAS, EA ;
MEHTA, J .
CLINICAL CARDIOLOGY, 1995, 18 (03) :131-135
[9]  
ENAS EA, 1994, INDIAN HEART J, V46, P1
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499